PL2632946T3 - Sposób wytwarzania pojedynczych domen zmiennych immunoglobulin - Google Patents

Sposób wytwarzania pojedynczych domen zmiennych immunoglobulin

Info

Publication number
PL2632946T3
PL2632946T3 PL11775994T PL11775994T PL2632946T3 PL 2632946 T3 PL2632946 T3 PL 2632946T3 PL 11775994 T PL11775994 T PL 11775994T PL 11775994 T PL11775994 T PL 11775994T PL 2632946 T3 PL2632946 T3 PL 2632946T3
Authority
PL
Poland
Prior art keywords
production
variable domains
single variable
immunoglobulin single
immunoglobulin
Prior art date
Application number
PL11775994T
Other languages
English (en)
Inventor
Ann Brige
Bart Walcarius
Yves Meyvis
Mauro Sergi
Original Assignee
Ablynx N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44872371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2632946(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ablynx N.V. filed Critical Ablynx N.V.
Publication of PL2632946T3 publication Critical patent/PL2632946T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL11775994T 2010-10-29 2011-10-28 Sposób wytwarzania pojedynczych domen zmiennych immunoglobulin PL2632946T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40822810P 2010-10-29 2010-10-29
EP11775994.4A EP2632946B1 (en) 2010-10-29 2011-10-28 Method for the production of immunoglobulin single variable domains
PCT/EP2011/068982 WO2012056000A1 (en) 2010-10-29 2011-10-28 Method for the production of immunoglobulin single variable domains

Publications (1)

Publication Number Publication Date
PL2632946T3 true PL2632946T3 (pl) 2018-06-29

Family

ID=44872371

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17192342.8T PL3279214T3 (pl) 2010-10-29 2011-10-28 Sposób wytwarzania pojedynczych domen zmiennych immunoglobuliny
PL11775994T PL2632946T3 (pl) 2010-10-29 2011-10-28 Sposób wytwarzania pojedynczych domen zmiennych immunoglobulin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17192342.8T PL3279214T3 (pl) 2010-10-29 2011-10-28 Sposób wytwarzania pojedynczych domen zmiennych immunoglobuliny

Country Status (9)

Country Link
US (2) US20130261288A1 (pl)
EP (3) EP4458858A3 (pl)
DK (2) DK3279214T3 (pl)
ES (2) ES2660895T3 (pl)
HU (1) HUE069364T2 (pl)
NO (1) NO2632946T3 (pl)
PL (2) PL3279214T3 (pl)
PT (1) PT2632946T (pl)
WO (1) WO2012056000A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE069364T2 (hu) 2010-10-29 2025-03-28 Ablynx Nv Eljárás immunglobulin variábilis egydomének elõállítására
WO2014087010A1 (en) 2012-12-07 2014-06-12 Ablynx N.V. IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
EP3444278A1 (en) 2013-02-26 2019-02-20 Roche Glycart AG Bispecific t cell activating antigen binding molecules
PL3294319T3 (pl) 2015-05-13 2024-10-07 Ablynx Nv Polipeptydy rekrutujące komórki t na podstawie reaktywności cd3
LT3611192T (lt) 2015-05-13 2025-06-25 Ablynx N.V. T ląstelių rekrutingo polipeptidai tcr alfa/beta reaktyvumo pagrindu
IL266506B2 (en) 2016-11-16 2025-05-01 Ablynx Nv T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
US20230136595A1 (en) 2020-03-30 2023-05-04 Ablynx Nv Method for the production and purification of multivalent immunoglobulin single variable domains
PH12023500009A1 (en) 2020-12-18 2024-03-11 Ablynx Nv T cell recruiting polypeptides based on tcr alpha/beta reactivity
TW202423965A (zh) 2022-07-27 2024-06-16 比利時商艾伯霖克斯公司 與新生兒fc受體的特定表位結合之多肽
CN120712282A (zh) 2023-02-17 2025-09-26 阿布林克斯有限公司 结合新生儿fc受体的多肽
TW202517676A (zh) 2023-07-05 2025-05-01 比利時商艾伯霖克斯公司 用於治療IgG相關疾病及病症之改良FcRn拮抗劑
WO2025061919A1 (en) 2023-09-22 2025-03-27 Ablynx Nv Bi- and multivalent albumin binders
WO2025207946A1 (en) 2024-03-28 2025-10-02 Genzyme Corporation Polypeptides binding to a specific epitope of the transferrin receptor 1

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
ATE427968T1 (de) 1992-08-21 2009-04-15 Univ Bruxelles Immunoglobuline ohne leichtkette
ES2162863T3 (es) 1993-04-29 2002-01-16 Unilever Nv Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
FR2708622B1 (fr) 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
CA2258518C (en) 1996-06-27 2011-11-22 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Recognition molecules interacting specifically with the active site or cleft of a target molecule
EP1027439B1 (en) 1997-10-27 2010-03-17 Bac Ip B.V. Multivalent antigen-binding proteins
BR9907241A (pt) 1998-01-26 2000-10-17 Unilever Nv Biblioteca de expressão, processo para preparar a mesma, uso de uma fonte não imunizada de sequências de ácido nucleico, e, processos para preparar fragmentos de anticorpos e, para preparar um anticorpo
EP1141711A1 (en) 1999-01-05 2001-10-10 Unilever Plc Binding of antibody fragments to solid supports
ATE276359T1 (de) 1999-01-19 2004-10-15 Unilever Nv Verfahren zur herstellung von antikörperfragmenten
ID30380A (id) 1999-04-22 2001-11-29 Unilever Nv Penghambatan infeksi virus menggunakan protein pengikat antigen bervalensi tunggal
US6479280B1 (en) 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
EP1242460B1 (en) 1999-11-29 2006-10-18 Unilever Plc Immobilisation of proteins using a polypeptide segment
ATE440111T1 (de) 1999-11-29 2009-09-15 Bac Ip B V Immobilisierte antigenbindende moleküle aus einer domäne
ATE428733T1 (de) 2000-03-14 2009-05-15 Unilever Nv Variabele domänen der schweren kette eines antikörpers gegen menschliche ernährungslipasen und deren verwendungen
CA2380443C (en) 2000-05-26 2013-03-12 Ginette Dubuc Single-domain antigen-binding antibody fragments derived from llama antibodies
AU2002229639A1 (en) 2000-12-13 2002-06-24 De Haard, Johannes Joseph Wilhelmus Camelidae antibody arrays
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
EP1433793A4 (en) 2001-09-13 2006-01-25 Inst Antibodies Co Ltd METHOD FOR CREATING A CAMEL ANTIBODY LIBRARY
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
WO2003050531A2 (en) 2001-12-11 2003-06-19 Algonomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
WO2003062375A2 (en) * 2001-12-19 2003-07-31 Genentech, Inc. Stabilizing polypeptides which have been exposed to urea
JP4323317B2 (ja) 2001-12-21 2009-09-02 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー(ヴェーイーベー・ヴェーゼットウェー) 可変領域配列のクローニング方法
EP1461085A2 (en) 2002-01-03 2004-09-29 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Immunoconjugates useful for treatment of tumours
AT5962U1 (de) 2002-06-19 2003-02-25 Siro Beschlaege Metall Präsentationsvorrichtung für gegenstände
JPWO2004001865A1 (ja) 2002-06-19 2005-10-27 株式会社東芝 熱電素子とそれを用いた電子部品モジュールおよび携帯用電子機器
NZ540194A (en) 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP1558650A2 (en) 2002-11-08 2005-08-03 Ablynx N.V. Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
JP2006517789A (ja) 2003-01-10 2006-08-03 アブリンクス エン.ヴェー. 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用
US7461263B2 (en) 2003-01-23 2008-12-02 Unspam, Llc. Method and apparatus for a non-revealing do-not-contact list system
WO2005051979A1 (en) * 2003-02-21 2005-06-09 Akzo Nobel N.V. Prevention and/or delay of peptide/protein carbamylation in urea solutions utilizing non-ethylene diamine like compounds
AU2003264053A1 (en) 2003-08-12 2005-03-10 William M. Yarbrough Treatment for acne vulgaris and method of use
EP2251357A1 (en) 2003-11-07 2010-11-17 Ablynx N.V. Camelidae single domain antibodies VHH directed against epidermal growth factor receptor and uses therefor
US7563443B2 (en) * 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
US20080107601A1 (en) 2004-10-13 2008-05-08 Ablynx N.V. Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's Disease
EP1844073A1 (en) 2005-01-31 2007-10-17 Ablynx N.V. Method for generating variable domain sequences of heavy chain antibodies
CN103254309B (zh) 2005-05-18 2017-09-26 埃博灵克斯股份有限公司 针对肿瘤坏死因子α的改进的纳米体TM
PL2444424T3 (pl) 2005-05-20 2019-01-31 Ablynx N.V. Ulepszone Nanociała TM do leczenia zaburzeń, w których pośredniczy agregacja
AU2008219216A1 (en) 2007-02-21 2008-08-28 Ablynx N.V. Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
NZ581097A (en) * 2007-05-24 2012-03-30 Ablynx Nv Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
CA2697922A1 (en) * 2007-08-28 2009-03-12 Biogen Idec Ma Inc. Compositions that bind multiple epitopes of igf-1r
CA2706200A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Immunoglobulin constructs comprising multiple single variable domains and an fc portion
WO2010056550A1 (en) 2008-10-29 2010-05-20 Wyeth Llc Methods for purification of single domain antigen binding molecules
KR20130119990A (ko) 2009-04-10 2013-11-01 아블린쓰 엔.브이. Il-6r에 대한 개선된 아미노산 서열 및 il-6r 관련 질환 및 질병의 치료를 위한 그를 포함하는 폴리펩티드
US9464138B2 (en) 2009-04-30 2016-10-11 Ablynx N.V. Method for the production of domain antibodies
CA2764398A1 (en) 2009-06-05 2010-12-09 Erik Depla Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
EP2513145B1 (en) 2009-12-14 2018-01-24 Ablynx N.V. Single variable domain antibodies against ox40l, constructs and therapeutic use
HUE069364T2 (hu) 2010-10-29 2025-03-28 Ablynx Nv Eljárás immunglobulin variábilis egydomének elõállítására

Also Published As

Publication number Publication date
US20200392214A9 (en) 2020-12-17
ES2996232T3 (en) 2025-02-12
EP3279214A1 (en) 2018-02-07
EP2632946A1 (en) 2013-09-04
EP3279214B1 (en) 2024-10-09
NO2632946T3 (pl) 2018-05-05
EP4458858A3 (en) 2025-02-19
HUE069364T2 (hu) 2025-03-28
DK3279214T3 (da) 2024-12-09
US20130261288A1 (en) 2013-10-03
PL3279214T3 (pl) 2025-03-24
EP2632946B1 (en) 2017-12-06
EP4458858A2 (en) 2024-11-06
US20200062834A1 (en) 2020-02-27
DK2632946T3 (en) 2018-03-12
PT2632946T (pt) 2018-03-01
ES2660895T3 (es) 2018-03-26
WO2012056000A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
HUE051430T2 (hu) Eljárás variábilis domének elõállítására
HUE069364T2 (hu) Eljárás immunglobulin variábilis egydomének elõállítására
PL2424889T3 (pl) Sposób wytwarzania przeciwciał domenowych
PT2691415T (pt) Método para produção de formulações sólidas compreendendo domínios variáveis únicos de imunoglobulina
BR112012020964A2 (pt) método de produção de imunoglobulina
IL220404A (en) Antiseptic antibodies
ZA201300146B (en) Process for the production of para-xylene
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
ZA201305971B (en) Method for the purification of biphephos
IL207945A0 (en) Method for the production of carbohydrates
IL249501B (en) A process for creating antibodies
SG10201508779UA (en) Process for the production of paraxylene
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
IL248217B (en) A method for the production of inganol-3-englate
IL224318B (en) A method for the automated synthesis of small molecules
SG11201400405TA (en) Caninised antibodies and method for the production of same
SI2784056T1 (sl) Postopek za selektivno produkcijo n-metil-para anizidina
LT2696959T (lt) Aplinkai nekenksmingas cemento gamybos būdas
IL223290A (en) Anti-1α-il antibodies for the treatment of arthritis
ZA201205844B (en) Process for the production of anhydrides
GB2495884B (en) A method of increasing the effect of an activated-potentiated form of an antibody
HUE044066T2 (hu) Eljárás metilén-difenil-diizocianát elõállítására
IL229375A0 (en) A method for diagnosing rheumatoid arthritis
PL393525A1 (pl) Sposób wytwarzania rury z tworzywa termoplastycznego
IL230159A0 (en) Method for the production of 2-amino-5-cyano-n,3-dimethylbenzamide